These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

484 related articles for article (PubMed ID: 24488421)

  • 1. Limitations in the classification of childhood-onset rheumatoid arthritis.
    Ferrell EG; Ponder LA; Minor LS; Angeles-Han ST; Kennedy CW; Rouster-Stevens KA; Rohani-Pichavant M; Vogler LB; Prahalad S
    J Rheumatol; 2014 Mar; 41(3):547-53. PubMed ID: 24488421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determination of anti-cyclic citrullinated peptide antibodies in the sera of patients with juvenile idiopathic arthritis.
    Low JM; Chauhan AK; Kietz DA; Daud U; Pepmueller PH; Moore TL
    J Rheumatol; 2004 Sep; 31(9):1829-33. PubMed ID: 15338508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of anti-cyclic citrullinated peptide antibodies may be beneficial in RF-negative juvenile idiopathic arthritis patients.
    Spârchez M; Miu N; Bolba C; Iancu M; Spârchez Z; Rednic S
    Clin Rheumatol; 2016 Mar; 35(3):601-7. PubMed ID: 25994613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibodies to Cyclic Citrullinated Peptides in Patients With Juvenile Idiopathic Arthritis and Patients With Rheumatoid Arthritis: Shared Expression of the Inherently Autoreactive 9G4 Idiotype.
    Peckham H; Cambridge G; Bourke L; Sen D; Radziszewska A; Leandro M; Ioannou Y
    Arthritis Rheumatol; 2017 Jul; 69(7):1387-1395. PubMed ID: 28380667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Repeated anticitrullinated protein antibody and rheumatoid factor assessment is not necessary in early arthritis: results from the ESPOIR cohort.
    Gossec L; Paternotte S; Combe B; Meyer O; Dougados M
    J Rheumatol; 2014 Jan; 41(1):41-6. PubMed ID: 24241481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic accuracy of anti-cyclic citrullinated peptide antibodies in juvenile idiopathic arthritis.
    Kasapçopur O; Altun S; Aslan M; Karaarslan S; Kamburoglu-Göksel A; Saribas S; Arisoy N; Kocazeybek B
    Ann Rheum Dis; 2004 Dec; 63(12):1687-9. PubMed ID: 15547097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-cyclic citrullinated peptide antibodies in patients with juvenile idiopathic arthritis.
    Habib HM; Mosaad YM; Youssef HM
    Immunol Invest; 2008; 37(8):849-57. PubMed ID: 18991100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-MCV and anti-CCP antibodies-diagnostic and prognostic value in children with juvenile idiopathic arthritis (JIA).
    Lipinska J; Lipinska S; Kasielski M; Smolewska E
    Clin Rheumatol; 2016 Nov; 35(11):2699-2706. PubMed ID: 27457366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Measurement and evaluation of isotypes of anti-citrullinated fibrinogen and anti-citrullinated alpha-enolase antibodies in juvenile idiopathic arthritis.
    Moore TL; Gillian BE; Crespo-Pagnussat S; Feller L; Chauhan AK
    Clin Exp Rheumatol; 2014; 32(5):740-6. PubMed ID: 25068682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of age on prevalence of anticitrullinated protein/peptide antibodies in polyarticular juvenile idiopathic arthritis.
    Dewint P; Hoffman IE; Rogge S; Joos R; Union A; Dehoorne J; Delanghe J; Veys EM; De Keyser F; Elewaut D
    Rheumatology (Oxford); 2006 Feb; 45(2):204-8. PubMed ID: 16188943
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The diagnostic value of anti-cyclic citrullinated peptide (CCP) antibodies in children with Juvenile Idiopathic Arthritis.
    Brunner J; Sitzmann FC
    Clin Exp Rheumatol; 2006; 24(4):449-51. PubMed ID: 16956438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-cyclic citrullinated peptide: diagnostic and prognostic values in juvenile idiopathic arthritis and rheumatoid arthritis in a Chinese population.
    Kwok JS; Hui KH; Lee TL; Wong W; Lau YL; Wong RW; Kim DL; Jones BM
    Scand J Rheumatol; 2005; 34(5):359-66. PubMed ID: 16234183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic performance of anti-citrullinated protein/peptide antibodies in juvenile idiopathic arthritis.
    Pang SY; Liu HY; Huang YJ; Liu YF; Dai YM; Zeng P; Zeng HS
    Genet Mol Res; 2016 May; 15(2):. PubMed ID: 27323035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phenotypic Characterization of Juvenile Idiopathic Arthritis in African American Children.
    Fitzpatrick L; Broadaway KA; Ponder L; Angeles-Han ST; Jenkins K; Rouster-Stevens K; Pelajo CF; Conneely K; Epstein MP; Lopez-Benitez J; Vogler LB; Prahalad S;
    J Rheumatol; 2016 Apr; 43(4):799-803. PubMed ID: 26879356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of ILAR classification criteria for juvenile idiopathic arthritis in Spanish children.
    Merino R; De Inocencio J; García-Consuegra J
    J Rheumatol; 2001 Dec; 28(12):2731-6. PubMed ID: 11764225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Profile of Indian patients with juvenile onset chronic inflammatory joint disease using the ILAR classification criteria for JIA: a community-based cohort study.
    Kunjir V; Venugopalan A; Chopra A
    J Rheumatol; 2010 Aug; 37(8):1756-62. PubMed ID: 20516021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-cyclic citrullinated peptide (anti-CCP) antibodies in children with juvenile idiopathic arthritis.
    van Rossum M; van Soesbergen R; de Kort S; ten Cate R; Zwinderman AH; de Jong B; Dijkmans B; van Venrooij WJ
    J Rheumatol; 2003 Apr; 30(4):825-8. PubMed ID: 12672206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of anti-cyclic citrullinated peptide antibodies, anti-citrullin antibodies, and IgM and IgA rheumatoid factors with serological parameters of disease activity in rheumatoid arthritis.
    Greiner A; Plischke H; Kellner H; Gruber R
    Ann N Y Acad Sci; 2005 Jun; 1050():295-303. PubMed ID: 16014545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A comparative evaluation of the diagnostic value of anti-cyclic citrullinated peptide and rheumatoid factor in rheumatoid arthritis].
    Cho SY; Kang SY; Lee HJ; Lee WI
    Korean J Lab Med; 2008 Feb; 28(1):39-45. PubMed ID: 18309254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibodies to mutated citrullinated vimentin and antibodies to cyclic citrullinated peptides in juvenile idiopathic arthritis.
    Kuna AT; Lamot L; Miler M; Harjacek M; Simundic AM; Vrkic N
    Clin Chem Lab Med; 2009; 47(12):1525-30. PubMed ID: 19842993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.